Related Experiment Videos
Linear IgA disease with haemorrhagic pompholyx and dapsone-induced neutropenia
1South Warwickshire Hospital, Warwick, U.K.
The British Journal of Dermatology
|August 1, 1991
Abstract:
A case of haemorrhagic pompholyx occurring in a 29-year-old man with linear IgA disease is described. There were several features in our patient that are usually seen in chronic bullous disease of childhood. Treatment with dapsone cleared the eruption but induced a progressive yet reversible neutropenia.
Insights
A rare case of hemorrhagic pompholyx in a patient with linear IgA disease presented with childhood bullous disease features. Dapsone treatment resolved the rash but caused reversible neutropenia.
Area of Science:
- Dermatology
- Immunology
Background:
- Linear IgA disease is a rare autoimmune blistering disease.
- Haemorrhagic pompholyx is an uncommon variant characterized by blood-filled blisters.
Observation:
- A 29-year-old man with linear IgA disease presented with haemorrhagic pompholyx.
- The patient exhibited clinical features typically associated with chronic bullous disease of childhood.
Findings:
- Dapsone therapy effectively resolved the haemorrhagic pompholyx eruption.
- A notable side effect of dapsone treatment was the induction of progressive, yet reversible, neutropenia.
Implications:
- This case highlights the overlap in clinical presentation between adult linear IgA disease and childhood bullous diseases.
- The findings underscore the importance of monitoring for neutropenia during dapsone treatment for blistering disorders.